HDAC inhibitors (CrystalGenomics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHDAC inhibitors (CrystalGenomics)
Drug Alias Namehistone deacetylase inhibitors (CrystalGenomics)CGMC-0006CGMC-0005
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCrystalgenomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrystalgenomics Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A